Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Tango Therapeutics Inc (TNGX)

Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference GlobeNewswire - Tue Sep 1, 6:00AM CDT

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (“Tango Therapeutics” or the “Company”) today announced that members of the management team are scheduled to...

TNGX : 22.87 (+2.33%)
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference GlobeNewswire - Tue Sep 1, 6:00AM CDT

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (“Tango Therapeutics” or the “Company”) today announced that members...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights GlobeNewswire - Tue Aug 11, 6:00AM CDT

Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive Phase 1/2 data Phase 1/2 data from combination...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights GlobeNewswire - Tue Aug 11, 6:00AM CDT

Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Announces Executive Chair Transition GlobeNewswire - Thu Aug 6, 5:24PM CDT

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Announces Executive Chair Transition GlobeNewswire - Thu Aug 6, 5:24PM CDT

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Appoints Robert Azelby to Board of Directors GlobeNewswire - Mon Jun 22, 3:05PM CDT

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Appoints Robert Azelby to Board of Directors GlobeNewswire - Mon Jun 22, 3:05PM CDT

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering GlobeNewswire - Tue Jun 9, 9:49PM CDT

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of...

TNGX : 22.87 (+2.33%)
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering GlobeNewswire - Tue Jun 9, 9:49PM CDT

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage biotechnology company committed to...

TNGX : 22.87 (+2.33%)

Barchart Exclusives

Okta Stock Has More Than Doubled in 2026. AI Agents Could Drive the Next Leg Higher. Barchart - Wed Sep 2, 6:30AM CDT
Okta is expanding beyond traditional identity security as companies deploy more AI agents that require authentication, permissions and ongoing security controls. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.